Clinical Studies 14.1 Attention Deficit Hyperactivity Disorder (ADHD) Pediatric Patients Ages 6 to 12 Years with ADHD A double-blind, randomized, placebo-controlled, parallel-group study (Study 1) was conducted in pediatric patients ages 6 to 12 years (N=290) who met DSM-IV criteria for ADHD (either the combined type or the hyperactive-impulsive type)
It is important to distinguish between normal injection site reactions and true allergic responses
Bromocriptine should not be routinely used to stop breast milk production
In STEP-1 (N=1,961), 29.7% of participants randomized to semaglutide 2.4 mg reported diarrhea over 68 weeks, compared with 15.9% in the placebo group [4]
This page describes laboratory research only
It has been determined for years that after only single bouts of moderate to high-intensity total IGF-1 plasma levels rise up to 1030 % and peak only after 510 min after the onset of the training [287]